AHFS March 2023 Update
| This update contains 9 new monographs, 13 revised monographs, 61 discontinued monographs and 2 new MedWatch alerts. New monographs: Adagrasib; Anacaulase (Topical); Fecal microbiota, live; Futibatinib; Lecanemab; Lenacapavir Sodium; Mosunetuzumab-axgb; Sirolimus Protein-bound Particles; Ublituximab. Revised monographs: Amivantamab-vmjw; Evolocumab; Idelalisib; Ketamine; Levoketoconazole; Lumacaftor and Ivacaftor; Lumateperone; Mifepristone; Pneumococcal Vaccine; Rolapitant; Tezacaftor and Ivacaftor; Trametinib Dimethyl Sulfoxide; Vutrisiran. Discontinued monographs: Abametapir; Acrivastine; Alefacept; Altretamine; Amifampridine; Aminohippurate; Aurothioglucose/Gold Sodium Thiomalate; Belantamab Mafodotin-blmf; Benzyl Alcohol; Benzyl Benzoate; Butabarbital; Cefditoren; Ceftibuten; Cellulose Sodium Phosphate; Collagenase Clostridium Histolyticum-aaes; Denileukin; Desirudin; Doripenem; Emedastine; Eprosartan; Etidronate; Fluoxymesterone; Gallium Nitrate; Guanabenz; Hexachlorophene; Hydrogen Peroxide 40%; Hydroxyethyl Starch 130/0.4; Indacaterol; Ingenol Mebutate; Invert Sugar; Isoxsuprine; Liotrix; Lorcaserin; Lutropin Alfa; Maprotiline; Mechlorethamine; Mequinol/Tretinoin; Metaproterenol; Methyclothiazide; Mipomersen; Monobenzone; Morrhuate Sodium; Nedocromil; Nesiritide; Ofatumumab; Panobinostat; Pemirolast; Propantheline; Rimexolone; Saquinavir; Secobarbital; Sodium Thiosalicylate; Tegaserod; Teniposide; Ticlopidine; TOLAZamide; TOLBUTamide; Tolmetin; Umbralisib; Urea 40-50% Injection; Zoster Vaccine Live. New Medwatch alerts on the following monographs: Blinatumomab; Tixagevimab and Cilgavimab. |